Currently Enrolling Trials

1. A multi-center, randomized, double blind, parallel group study to demonstrate the efficacy and safety of XXX topical 0.1% to XXX in moderate to severe facial acne vulgaris.
2. A randomized, double blind, active-controlled, multi-center, parallel group, dose ranging study assessing the safety and efficacy of XXX to XXX among immunocompetent patients with an acute episode of herpes zoster (shingles).
3. Pharmacodynamic study of XXX oily spray applied twice daily for 3 weeks under conditions of maximized use in adults with plaque-type psoriasis.
4. A Phase 2B multi-center, double blind, randomized, dose ranging clinical trial to evaluate XXX in the treatment of moderate to severe acne vulgaris with nodular involvement.
5. A multi-center, open-label, controlled Phase II study to evaluate safety and immunogenicity of XXX smallpox vaccine in 18-40 year old subjects diagnosed with atopic dermatitis.
6. A multi-center, double blind, randomized, parallel group, vehicle controlled study to determine the clinical equivalence of XXX cream 5% to XXX in the treatment of actinic keratosis.
7. A 12-week, randomized, double-blind, multi-center, phase IV study comparing the efficacy and safety of XXX x2 actuations twice daily versus XXX x2 inhalations twice daily, in adult and adolescent African American subjects with asthma.
8. A multi-center, double blind, randomized, vehicle controlled, parallel group study comparing XXX cream 0.03% to XXX cream 0.03% and both active treatments to a vehicle control in the treatment of atopic dermatitis.
9. A randomized, double blind, vehicle-controlled, dose randing study of XXX cream for the treatment of superficial basal cell carcinoma.
10. A multi-center, double-blind, placebo-controlled, dose-ranging, study to assess the efficacy and safety of XXX in the treatment of subjects with moderate to severe chronic plaque psoriasis.
11. An open-label study of XXX cream 3% twice daily for the treatment of in situ cutaneous squamous cell carcinoma.
12. A Phase 3, multi-center, randomized, double blind, active and vehicle-controlled study of the safety and efficacy of XXX and XXX and XXX and vehicle for the treatment of acne vulgaris.
13. A multi-center, double blind, randomized, parallel group, vehicle controlled study to determine the clinical equivalence of XXX cream 5% to XXX in the treatment of actinic keratosis.
14. A multi-center, randomized, double blind, placebo-controlled, parallel group efficacy and safety study of two doses of XXX in patients with atopic dermatitis.            
15. A randomized, double blind clinical trial to evaluate the safety and efficacy of XXX for the treatment of androgenetic alopecia in males.
16. A multi-center, double blind, randomized, placebo-controlled phase 3 clinical trial of XXX for the treatment of human head lice infestations of pediatric and adult subjects.